LEGAPAS®

Produit de santé naturel homologué au Canada

Titulaire: Pascoe Canada
NPN ou DIN-HM: 80002081
Statut: Licence active
Date de licence: 8 septembre 2006
Date de révision: Non renseignée
Forme: Extrait fluide
Voie d'administration: Orale
Type de demande: Officinale

Si ce produit était vendu en France

Aucun point relevé par les règles que nous appliquons.

Une quantité quotidienne est calculée uniquement pour une posologie adulte orale explicite, exprimée par jour et dans une unité solide correspondant à la forme du produit. Les unités ambiguës, liquides, poudres et doses pédiatriques ne sont pas extrapolées. Une quantité non calculée n'est pas comparée aux limites de dose. Cette analyse ne constitue pas une autorisation de vente en France ni une évaluation de sécurité ou d'efficacité.

Composition

Composition médicinale non renseignée.

Ingrédients non médicinaux

Eau purifiée, Alcool

Doses recommandées au Canada

Population	Âge	Quantité par prise	Fréquence
Adultes	Non précisée	minimum : 0,9 g ; maximum : 1,5 g	1 Tous les jours
Enfants	minimum : 12 ans	minimum : 0,9 g ; maximum : 1,5 g	1 Tous les jours

Usages autorisés au Canada

Tradtionally used as a laxative.

Un usage autorisé au Canada n'est pas une allégation de santé autorisée dans l'Union européenne. Consultez le registre des allégations de santé.

Mises en garde au Canada

Effets indésirables connus
Additional information-only on the package insert leaflet: Side Effects: Very rarely cramp-like gastrointestinal symptoms; In these cases, the dose will have to be reduced. In the course of treatment, you may observe harmless discoloration of your urine. prolonged use or use of higher doses (abuse) may cause disturbances of the water and electrolyte balance. Diarrhea may lead to potassium loss in particular. Potassium loss in turn may give rise to disorders of heart function and muscle weakness, especially if cardiac glycosides (drugs that strengthen the heart muscle), diuretics (drugs that increase urinary output), and/or cortisone and cortisone like-drugs (adrenal cortical steroids) are being taken concomitantly. Prolonged use may lead to excretion of protein and blood in urine. Patients may also experience discoloration of the intestinal mucosa (pseudomelanosis coli), which usually resolves upon discontinuation of the product. Violations of Dosing Schedule and Overdosage: accidental or intetional overdosage may produce painful bowel cramps and severe diarrhoea resulting in water and electrolyte loss, and possibly intense gastrointestinal symptoms. In case of overdosage, call a doctor immediately. Do not take a double dose next time but continue treatment as described in the dosing instructions if you miss a dose.
Contre-indications
Do not use if you have abdominal pain, nausea, fever, vomiting, hemorrhoids or if you have chronic gastrointestinal disorder. Do not use if you are thiazide diuretics, corticosteroids, licorice root, or other drugs that may aggravate electrolyte imbalance. Do not use if you are pregnant or breastfeeding. Do not within 2 hours of another medicine. Additional information-only on the package insert leaflet: Drug Interactions: Chronic use or abuse may lead to potassium deficiency and thus increase the effects of certain drugs that strengthen the heart muscle (cardiac glycosides) and interfere with the effects of drugs for heart rhythm disturbance (antiarrhymics). Potassium loss may be increased by the concomtiant use of certain drugs that increase urinary output (diuretics), cortisone and cortisone-like drugs (corticosteroids) or liquorice root.